Nicotine Replacement Therapy (NRT) Products Market, by Type (Sprays, Inhalers, Chewing gums, Transdermal patches, Lozenges, Sublingual tablets), Application (Home, Hospital), and Region (North America, Europe, Asia-Pacific, and the Rest of the World).
Nicotine Replacement Therapy (NRT) Products Market, by Type (Sprays, Inhalers, Chewing gums, Transdermal patches, Lozenges, Sublingual tablets), Application (Home, Hospital), and Region (North America, Europe, Asia-Pacific, and the Rest of the World)....
Nicotine replacement therapy is a type of therapy used to treat people with tobacco use disorder by taking nicotine by means other than tobacco. This therapy helps with quitting smoking or stopping chewing tobacco. It increases the chance of quitting tobacco smoking by about 55%. The different nicotine replacement therapy products include sprays, inhalers, chewing gums, and transdermal patches among others.
The growth of the global nicotine replacement therapy (NRT) products market is driven by a host of factors, some of which are noted below:
Increasing awareness among consumers about the ill effects of smoking.
The rising number of smokers across geographies
In addition to this, increasing government initiatives aimed at creating awareness about the adverse impact of smoking on health is likely to create lucrative opportunities for the players operating.
COVID-19 Impact
The outbreak of the COVID-19 virus has affected the growth of the tobacco industry significantly. Stringent lockdown measures and restricted movement of people affected the product supply for a short period of time.
Key Players
Key players operating in the global nicotine replacement therapy (NRT) products market are:
"The home segment accounted for the largest market share."
The market has been bifurcated into homes and hospitals. Under these, the home segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period. The segment growth can be attributed to the increasing consumption of nicotine replacement therapy products across households.
Regional Insights
"Asia-Pacific accounted for the largest market share."
The market in Asia-Pacific accounted for the largest market share in 2020 and is projected to grow at a significant CAGR during the assessment period. The segment growth is primarily attributed to the presence of a large number of smokers coupled with the presence of various tobacco manufacturers. The market growth in the North American region is expected to be driven by the increasing prevalence of smoking-related health disorders.
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into market dynamics and will enable strategic decision-making for existing market players as well as those willing to enter the market.
What deliverables will you get in this report?
Key questions this report answers
Relevant contents in the report
How big is the sales opportunity?
In-depth analysis of the Nicotine Replacement Therapy (NRT) Products Market
How lucrative is the future?
Market forecast and trend data and emerging trends
Which regions offer the best sales opportunities?
Global, regional and country level historical data and forecasts
Which are the most attractive market segments?
Market segment analysis and forecast
Which are the top players and their market positioning?
Porter’s five forces analysis, PEST analysis, Life cycle analysis
What are the factors affecting the market?
Drivers & challenges
Will I get the information on my specific requirement?
10% free customization
Research Methodology
This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tool. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data. We conducted more than 10 detailed primary interviews with companies across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.
Customization Options
With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:
Company Profiling
Detailed profiling of additional market players (up to three players)
SWOT analysis of key players (up to three players)
Competitive Benchmarking
Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances
Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected].
Recent News & Developments
In September 2023: E-cigarettes, Varenicline, and Cytisine were found to be the most effective stop-smoking aids.
A comprehensive recent study has determined that nicotine e-cigarettes, varenicline, and cytisine represent the most effective choices presently accessible for aiding smokers in achieving long-term cessation, defined as abstaining from smoking for a duration of at least six months.
In August 2023: The realm of smoking cessation undergoes a revitalization as Blip enters the scene, reshaping the concept of nicotine cessation for contemporary smokers and vapers. Blip introduces FDA-approved nicotine replacement therapy (NRT) solutions that have the potential to increase the likelihood of successful quitting twofold. Additionally, Blip fosters a supportive community for individuals at any stage of their cessation journey, firmly convinced that human connections play a pivotal role in the journey toward achieving and maintaining a nicotine-free life.
LOADING
LOADING
×
Please enter your contact details. It will allow our analysts to reach out to you.
The report is delivered digitally through our online portal. Buyers receive login credentials from our team to access the report and may update their credentials at any time after the initial login.
Delivery timelines depend on the status of the report:
Published reports are typically delivered within 24 hours.
If the dataset is ready but the report is still being prepared, the dataset is usually delivered within 24 hours, while the completed report is delivered within 2 weeks.
For ongoing studies, both the dataset and the final report are generally delivered within 4–5 weeks .
For the most accurate delivery timeline, please contact us to confirm the current status of the report.
Yes. The scope of the report can be fully customized to align with your specific research objectives and information requirements.
Please contact us at [email protected], and our team will be happy to discuss your requirements and propose a tailored solution.
Yes. Selected sections of the report can be purchased separately based on your requirements. Please contact us at [email protected] to discuss your needs.
Yes, AI can help gather publicly available information, but its outputs are only as reliable as the data it accesses. Stratview Research reports are built using validated data, extensive primary interviews with industry stakeholders, and the expertise of our experienced research team.
Additionally, many critical insights, including market dynamics, competitive intelligence, and industry-specific trends, are not publicly available and therefore cannot be captured through AI alone.
Nicotine replacement therapy is a type of therapy used to treat people with tobacco use disorder by taking nicotine by means other than tobacco. This therapy helps with quitting smoking or stopping chewing tobacco. It increases the chance of quitting tobacco smoking by about 55%. The different nicotine replacement therapy products include sprays, inhalers, chewing gums, and transdermal patches among others.
Pfizer Inc. (US), Cipla Limited (India), Novartis International AG (Switzerland), GlaxoSmithKline plc (UK), The Takeda Pharmaceutical Company Limited (Japan), McNeil (US), Revolymer (UK), Imperial Brands plc (UK) and VMR Products (India) are among the key players in the market.
Nicotine replacement therapy (NRT) products distributors, suppliers, manufacturers, logistics organizations, and government bodies are the target audience in the market.
